Biorunx Co., Ltd. is a South Korean private company located in Cheongju-si. The firm develops and manufactures anti cancer drugs. Seok-Chul Bae is currently the CEO of the company.

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients. Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia, due to Low- or Intermediate-1-risk Myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Revlimid is sold through proprietary risk-management distribution programs, to ensure safe and appropriate use of these pharmaceuticals. Vidaza is approved for the treatment of patients with MDS.

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

The Rural Development Administration (Korean: 농촌진흥청; Hanja: 農村振興廳, RDA) is one of an agriculture organizations in South Korea and is run under the Ministry of Agriculture, Food and Rural Affairs. The headquarters are in Wansan-gu, Jeonju.

Teijin Pharma Ltd. engages in the development, production, sales, and marketing of pharmaceuticals, and medical devices and supplies. The company operates in pharmaceutical and home healthcare businesses, focusing on bone and joint diseases, respiratory diseases, and cardiovascular and metabolic diseases. The company was founded in 2002 and is headquartered in Tokyo, Japan.

Oscotec, Inc. engages in the development, manufacture and sale of pharmaceutical products. The company operates through the following business divisions: New drug, and Medical materials. Its products include drugs for osteoporosis, arthritis, periodontal disease and cancer, functional food ingredients, dental bone graft materials, dental membrane, and dental supplies. The company was founded on December 8, 1998 and is headquartered in Seongnam-si, South Korea.

Regeneration Technologies, Inc. (RTI) is engaged in tissue-based innovations that are used to repair and promote the natural healing of human bone and other human tissues. RTI processes human musculoskeletal and other tissues, including bone, cartilage, tendon, ligament, pericardial and cardiovascular tissue in producing allograft implants. RTI's patented BioCleanse® tissue sterilization process is validated to eliminate bacteria, fungi, spores and viruses from the tissue. The company is located in Alachua, FL.

Biophilia provides regenerative medicine materials and implantable medical device solutions covering clinical surgery. They offer products for minimally invasive surgery, hernia and abdominal wall surgery, dentistry, neurosurgery, and protective products.

Lek Pharmaceuticals dd, a subsidiary of Novartis AG, is a company headquartered in Ljubljana, Slovenia, that develops, manufactures and markets drugs and pharmaceutical products. Robert Ljoljo is the CEO, in this role since 2019. On November 21, 2002 Novartis AG acquired Lek Pharmaceuticals dd for $689.24 million.

Yunnan Keats Regenerative Medicine Research Institute Co., Ltd., established on 2018-01-08, Business scope includes research on stem cell biotechnology,Development and technology transfer;Stem Cell Storage Technology Services;stem cell collection,detection,to prepare,Freezing and Serving;immune cell technology,Research on Medical Testing Technology,to develop,technology transfer,technical consulting;medical service;Health Information Consultation,Business Management Consulting;cosmetic,Medical Device Research,development and production;Domestic Trade,Material supply and marketing;Genetic Testing Technology Consulting;Genetic data analysis service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Dongguk University Industry-Academic Cooperation Foundation is for the promotion of tenants and entrepreneurship.

Cell2in, Inc. is a private company headquartered in Jongro-gu, the South Korea. The firm operates cell therapy.

UEA Enterprises Ltd., part of University of East Anglia, is a company headquartered in the United Kingdom. The firm identifies, evaluates, protects and wherever appropriate commercialize the results of research carried out by the employees and research students.

Peking Union Medical College Hospital, also known as Beijing Xiehe Hospital (Chinese: 北京协和医院), is a renowned general hospital in Beijing, China. It was founded in 1921 by Rockefeller Foundation and is affiliated to both Peking Union Medical College (PUMC) and Chinese Academy of Medical Sciences (CAMS). During the Cultural Revolution, it was renamed the "Anti-imperialist Hospital".

Qingdao Situo Xinyuan Cell Medicine Co., Ltd., established on 2017-12-12, Business scope includes cell therapy technology,Cell Therapy Products,cell antibody,Technology development of gene medicine;biological reagent(Free of Hazardous Chemicals)research and development,Sales;Immune Cells,Umbilical cord cells,placental cells,fat cells,Development of skin cell preservation technology(Clinical application without hematopoietic stem cell transplantation);cell collection;Development and research of derivatives related to cell therapy;Sales:Instrumentation,medical instruments,cosmetic,hygiene products,Health products;Research and development of biotechnology,consult,to promote,Serve,transfer;Import and export of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Runzhuowang Trading Co., Ltd., established on 2020-05-27, Business scope includes general items:food sales(Only sell prepackaged food);Daily necessities wholesale;Wholesale of edible agricultural products;gift flower sale;Sales of building materials;Metal Products Sales;Office Equipment Sales;Wholesale of hardware products;Sales of plastic products;Wholesale of sporting goods and equipment;needle textile sales;Wholesale shoes and hats;Clothing and apparel wholesale;Communication equipment sales;electronics sales;Fresh Fruit Wholesale;Wholesale Fresh Vegetables;Fresh Meat Wholesale;wholesale fresh eggs;Professional cleaning,to clean,Disinfection service;General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval);marketing planning;business management.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)